Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Development and validation of Multiplex Liquid Bead Array (MLBA) assay for the simultaneous expression of fourteen genes in Circulating Tumor Cells (CTCs).

Parisi CA, Markou A, Strati A, Kasimir-Bauer S, Lianidou ES.

Anal Chem. 2019 Jan 21. doi: 10.1021/acs.analchem.8b04975. [Epub ahead of print]

PMID:
30663875
2.

Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.

Panagopoulou M, Karaglani M, Balgkouranidou I, Biziota E, Koukaki T, Karamitrousis E, Nena E, Tsamardinos I, Kolios G, Lianidou E, Kakolyris S, Chatzaki E.

Oncogene. 2019 Jan 14. doi: 10.1038/s41388-018-0660-y. [Epub ahead of print]

PMID:
30643192
3.

Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.

Giannopoulou L, Zavridou M, Kasimir-Bauer S, Lianidou ES.

Transl Res. 2018 Oct 12. pii: S1931-5244(18)30186-5. doi: 10.1016/j.trsl.2018.10.003. [Epub ahead of print] Review.

PMID:
30391474
4.

Liquid Biopsies.

Lianidou E, Pantel K.

Genes Chromosomes Cancer. 2018 Nov 1. doi: 10.1002/gcc.22695. [Epub ahead of print] Review.

PMID:
30382599
5.

A pilot plasma-ctDNA ring trial for the Cobas® EGFR Mutation Test in clinical diagnostic laboratories.

Ntzifa A, Kroupis C, Haliassos A, Lianidou E.

Clin Chem Lab Med. 2018 Sep 29. pii: /j/cclm.ahead-of-print/cclm-2018-0676/cclm-2018-0676.xml. doi: 10.1515/cclm-2018-0676. [Epub ahead of print] No abstract available.

PMID:
30267626
6.

Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies.

Zavridou M, Mastoraki S, Strati A, Tzanikou E, Chimonidou M, Lianidou E.

Clin Chem. 2018 Oct;64(10):1522-1533. doi: 10.1373/clinchem.2018.292318. Epub 2018 Jul 17.

PMID:
30018056
7.

ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer.

Giannopoulou L, Mastoraki S, Buderath P, Strati A, Pavlakis K, Kasimir-Bauer S, Lianidou ES.

Gynecol Oncol. 2018 Aug;150(2):355-360. doi: 10.1016/j.ygyno.2018.05.026. Epub 2018 May 26.

PMID:
29807696
8.

ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment.

Mastoraki S, Strati A, Tzanikou E, Chimonidou M, Politaki E, Voutsina A, Psyrri A, Georgoulias V, Lianidou E.

Clin Cancer Res. 2018 Mar 15;24(6):1500-1510. doi: 10.1158/1078-0432.CCR-17-1181. Epub 2017 Dec 28.

PMID:
29284708
9.

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.

Politaki E, Agelaki S, Apostolaki S, Hatzidaki D, Strati A, Koinis F, Perraki M, Saloustrou G, Stoupis G, Kallergi G, Spiliotaki M, Skaltsi T, Lianidou E, Georgoulias V, Mavroudis D.

Cell Physiol Biochem. 2017;44(2):594-606. doi: 10.1159/000485115. Epub 2017 Nov 20.

10.

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.

Markou A, Lazaridou M, Paraskevopoulos P, Chen S, Świerczewska M, Budna J, Kuske A, Gorges TM, Joosse SA, Kroneis T, Zabel M, Sedlmayr P, Alix-Panabières C, Pantel K, Lianidou ES.

Clin Chem. 2018 Feb;64(2):297-306. doi: 10.1373/clinchem.2017.275503. Epub 2017 Nov 9.

PMID:
29122836
11.

Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).

Economopoulou P, Kotsantis I, Kyrodimos E, Lianidou ES, Psyrri A.

Oral Oncol. 2017 Nov;74:83-89. doi: 10.1016/j.oraloncology.2017.09.012. Epub 2017 Oct 2. Review.

PMID:
29103757
12.

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer.

Chimonidou M, Strati A, Malamos N, Kouneli S, Georgoulias V, Lianidou E.

Oncotarget. 2017 Jun 27;8(42):72054-72068. doi: 10.18632/oncotarget.18679. eCollection 2017 Sep 22.

13.

Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.

Strati A, Koutsodontis G, Papaxoinis G, Angelidis I, Zavridou M, Economopoulou P, Kotsantis I, Avgeris M, Mazel M, Perisanidis C, Sasaki C, Alix-Panabières C, Lianidou E, Psyrri A.

Ann Oncol. 2017 Aug 1;28(8):1923-1933. doi: 10.1093/annonc/mdx206.

PMID:
28838214
14.

Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.

Giannopoulou L, Kasimir-Bauer S, Lianidou ES.

Clin Chem Lab Med. 2018 Jan 26;56(2):186-197. doi: 10.1515/cclm-2017-0019. Review.

15.

Exosomes: A Cancer Theranostics Road Map.

Panagiotara A, Markou A, Lianidou ES, Patrinos GP, Katsila T.

Public Health Genomics. 2017;20(2):116-125. doi: 10.1159/000478253. Epub 2017 Jul 20. Review.

16.

miRNA-21 as a novel therapeutic target in lung cancer.

Markou A, Zavridou M, Lianidou ES.

Lung Cancer (Auckl). 2016 Mar 2;7:19-27. doi: 10.2147/LCTT.S60341. eCollection 2016. Review.

17.

RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.

Giannopoulou L, Chebouti I, Pavlakis K, Kasimir-Bauer S, Lianidou ES.

Oncotarget. 2017 Mar 28;8(13):21429-21443. doi: 10.18632/oncotarget.15249.

18.

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.

Kuske A, Gorges TM, Tennstedt P, Tiebel AK, Pompe R, Preißer F, Prues S, Mazel M, Markou A, Lianidou E, Peine S, Alix-Panabières C, Riethdorf S, Beyer B, Schlomm T, Pantel K.

Sci Rep. 2016 Dec 21;6:39736. doi: 10.1038/srep39736.

19.

Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis.

Parisi C, Mastoraki S, Markou A, Strati A, Chimonidou M, Georgoulias V, Lianidou ES.

Clin Chim Acta. 2016 Oct 1;461:156-64. doi: 10.1016/j.cca.2016.08.003. Epub 2016 Aug 7.

PMID:
27510924
20.

Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer.

Matthaios D, Balgkouranidou I, Karayiannakis A, Bolanaki H, Xenidis N, Amarantidis K, Chelis L, Romanidis K, Chatzaki A, Lianidou E, Trypsianis G, Kakolyris S.

Oncol Lett. 2016 Jul;12(1):748-756. Epub 2016 Jun 1.

Supplemental Content

Loading ...
Support Center